Epistaxis epidemiology and demographics
|
Epistaxis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Epistaxis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Epistaxis epidemiology and demographics |
|
Risk calculators and risk factors for Epistaxis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.
Overview
About 60 percent of people experienced epistaxis at least once, and about 6 percent of people looking for medical action at least once however, epistaxis is hardly lethal. It is more common in children and elderly patients
Epidemiology and demographics
The incidence of patients with epistaxis, which needed inpatients treatment to control bleeding was estimated to be 42 cases per 100,000 for men and 28 cases per 100,000 for women and For men over 85 years it's 222 per 100,000 in Thuringia, Germany.
Epistaxis is a frequently encountered ear, nose, and throat (ENT) condition by emergency providers in the United States, responsible for approximately 1 in 200 emergency department (ED) visits
Prevalence
About 60 percent of American people experienced epistaxis at least once, and about 6 percent of people looking for medical action. [1]
Case-fatality rate/Mortality rate
Although epistaxis is the most common emergency in ENT, mortality from epistaxis is rare. [2]
Age
Patients of all age groups may experience epistaxis, but it is more prevalent in children and elderly patients.[3]
Race
Based on some studies epistaxis is more common in Caucasian compared with African-Americans.[4]
Gender
Epistaxis is more common in males.[5]
References
- ↑ Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). "Clinical Practice Guideline: Nosebleed (Epistaxis)". Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
- ↑ Anghel AG, Soreanu CC, Dumitru M, Anghel I (2014). "Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic". Maedica (Buchar). 9 (2): 179–82. PMC 4296762. PMID 25705275.
- ↑ Pallin, Daniel J.; Chng, Yi-Mei; McKay, Mary Patricia; Emond, Jennifer A.; Pelletier, Andrea J.; Camargo, Carlos A. (2005). "Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001". Annals of Emergency Medicine. 46 (1): 77–81. doi:10.1016/j.annemergmed.2004.12.014. ISSN 0196-0644.
- ↑ Mauer, A. C.; Khazanov, N. A.; Levenkova, N.; Tian, S.; Barbour, E. M.; Khalida, C.; Tobin, J. N.; Coller, B. S. (2011). "Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults". Journal of Thrombosis and Haemostasis. 9 (1): 100–108. doi:10.1111/j.1538-7836.2010.04105.x. ISSN 1538-7933.
- ↑ Côrte, Filipa Camacho; Orfao, Tiago; Dias, Cláudia Camila; Moura, Carla Pinto; Santos, Margarida (2018). "Risk factors for the occurrence of epistaxis: Prospective study". Auris Nasus Larynx. 45 (3): 471–475. doi:10.1016/j.anl.2017.07.021. ISSN 0385-8146.